Browse drugs

…arm, 7.5% in the atezolizumab+bevacizumab arm, and 15.4% in the docetaxel (control) arm. There were no clear correlations of response or …

…aries between patients and within patients. Side effects due to bevacizumab treatment are also common. It would be of value to predict ther…

…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …

…sions First-line treatment with serplulimab in combination with bevacizumab and chemotherapy demonstrated promising antitumor activity and …

…tion and repeated transfusions. Angiogenesis inhibitors such as bevacizumab have been proposed as an alternative treatment for refractory d…

…s a significant challenge. As for systemic therapy, intravenous bevacizumab combined with chemotherapy has demonstrated clinical benefits i…

… 52.1%.Conclusions Nelmastobart plus trifluridine/tipiracil and bevacizumab was well tolerated, with no drug-related toxicities. BTN1A1 exp…

…red, followed by either 10 mg/kg of bevacizumab or 2.4 mg/kg of carboplatin. Serial MRI was obtained post-treatment to assess tumor respons…

…. For HCC-specific mortality, higher risks were associated with Lenvatinib (aHR 9.04; 95%CI 3.36-24.3; p<0.001), Sorafenib (aHR 5.82; 95%C…

…GF-A/VEGFR-1 loop within macrophages.Conclusion The addition of bevacizumab to chemoimmunotherapy was associated with improved survival in …

…fferent storage temperatures over a 28-day period.Methods Three bevacizumab 25 mg/mL vials (CT-P16) were stored punctured either light prot…

…uced vessel density.Conclusion The combination of FAP-IL2v plus atezolizumab with or without bevacizumab was consistent with the known safet…